When Deep Blue first defeated Kasparov: is a machine stronger than a radiologist at predicting prognosis in idiopathic pulmonary fibrosis?

Idiopathic pulmonary fibrosis (IPF) is a relentlessly progressive disease with a poor prognosis. Nevertheless, survival time varies substantially, with some patients experiencing an accelerated decline and a few living as long as 10 years after diagnosis [1]. Predicting the future for patients with IPF is challenging. Yet, this is of paramount importance given the clinical implications, such as initiation of treatment, inclusion in clinical trials, referral for lung transplantation or palliation. Quantitative CT data is prognostically more accurate than visual CT scoring in patients with IPF